CH622947A5 - Process for the production of a pharmaceutical composition which is in solid form and contains bismuth - Google Patents

Process for the production of a pharmaceutical composition which is in solid form and contains bismuth Download PDF

Info

Publication number
CH622947A5
CH622947A5 CH51075A CH51075A CH622947A5 CH 622947 A5 CH622947 A5 CH 622947A5 CH 51075 A CH51075 A CH 51075A CH 51075 A CH51075 A CH 51075A CH 622947 A5 CH622947 A5 CH 622947A5
Authority
CH
Switzerland
Prior art keywords
bismuth
solution
preheated
solid form
liquid
Prior art date
Application number
CH51075A
Other languages
German (de)
English (en)
Inventor
Christopher John Mcloughlin
Ross Brock Himstedt
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of CH622947A5 publication Critical patent/CH622947A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH51075A 1974-01-18 1975-01-16 Process for the production of a pharmaceutical composition which is in solid form and contains bismuth CH622947A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CH622947A5 true CH622947A5 (en) 1981-05-15

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
CH51075A CH622947A5 (en) 1974-01-18 1975-01-16 Process for the production of a pharmaceutical composition which is in solid form and contains bismuth

Country Status (18)

Country Link
JP (1) JPS5837284B2 (nl)
AT (1) AT349150B (nl)
AU (1) AU485660B2 (nl)
BE (1) BE824509A (nl)
CA (1) CA1040532A (nl)
CH (1) CH622947A5 (nl)
DE (1) DE2501787A1 (nl)
DK (1) DK151770C (nl)
ES (1) ES433908A1 (nl)
FI (1) FI750113A (nl)
FR (1) FR2258177B1 (nl)
GB (1) GB1478742A (nl)
IE (1) IE40361B1 (nl)
IT (1) IT1036072B (nl)
LU (1) LU71668A1 (nl)
NL (1) NL185130C (nl)
SE (1) SE437930B (nl)
ZA (1) ZA74385B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901508A1 (de) * 1989-01-19 1990-07-26 Falk Pharma Gmbh Wismut enthaltendes praeparat in fester form, arzneimittel worin es enthalten ist und verfahren zu seiner herstellung

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901508A1 (de) * 1989-01-19 1990-07-26 Falk Pharma Gmbh Wismut enthaltendes praeparat in fester form, arzneimittel worin es enthalten ist und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
DK151770C (da) 1989-11-06
DE2501787C2 (nl) 1987-11-12
SE7500501L (nl) 1975-07-19
ATA31875A (de) 1978-08-15
FR2258177A1 (nl) 1975-08-18
IT1036072B (it) 1979-10-30
NL7500552A (nl) 1975-07-22
IE40361L (en) 1975-07-18
AU485660B2 (en) 1977-07-28
AT349150B (de) 1979-03-26
SE437930B (sv) 1985-03-25
DK151770B (da) 1988-01-04
LU71668A1 (nl) 1975-06-24
IE40361B1 (en) 1979-05-09
ZA74385B (en) 1975-08-27
NL185130B (nl) 1989-09-01
CA1040532A (en) 1978-10-17
JPS5837284B2 (ja) 1983-08-15
NL185130C (nl) 1990-02-01
GB1478742A (en) 1977-07-06
DK12675A (nl) 1975-09-15
FI750113A (nl) 1975-07-19
BE824509A (fr) 1975-07-17
JPS50116623A (nl) 1975-09-12
DE2501787A1 (de) 1975-07-24
ES433908A1 (es) 1976-11-16
AU7729375A (en) 1976-07-15
FR2258177B1 (nl) 1978-07-21

Similar Documents

Publication Publication Date Title
CH622947A5 (en) Process for the production of a pharmaceutical composition which is in solid form and contains bismuth
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2636152C2 (de) Verfahren zur Herstellung von Dragees
DD238529A5 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit einem gehalt an ibuprofen
DE2128674A1 (de) Clathratverbindungen
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE2517413A1 (de) Dermatologisch verwendbares mittel
DE1617528B1 (de) Arzneipräparate zur Behandlung von Erkrankungen des Augenhintergrundes
DD144719A5 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
DE1915798C3 (de) Antacidum-Präparat in Form einer wäßrigen Suspension
DE3203310A1 (de) Pharmazeutische zusammensetzung zur behandlung von erkrankungen der mundhoehle
DE2519528C2 (nl)
DE2166355C2 (de) Verwendung von d,1-Sobrerol bei der Balsamtherapie der Atemwege
DE3632334C2 (nl)
DE2510663B2 (de) Aluminiumpolyhydroxisulfat sowie dieses enthaltendes Arzneimittel
DE1936723C2 (de) Salze von Chinarindenalkoloiden und Verfahren zu ihrer Herstellung
DE3419129A1 (de) Nifedipinpraeparate und verfahren zu ihrer herstellung
DE2047049C3 (de) Calciumsalz der 6-(N-Acetylamino)hexansSure, Verfahren zu seiner Herstellung und Arzneimittel mit einem Gehalt an diesem Salz
EP0429856B1 (de) Neue Arzneizubereitungen, ein Metallsalz des Ibuprofens enthaltend und Verfahren zur Herstellung derselben
DE2157201A1 (de) Verbesserte orale applikationsform von raubasin
CH634546A5 (de) Verfahren zur herstellung von komplexen verbindungen von aminodicarbonsaeuren mit magnesium und halogenen.
DE1543733C3 (de) Aluminium-bis-alpha-(p-chlorphenoxy) isobutyrat und diese Verbindung als Wirkstoff enthaltende Hellmittel
DE2951132C2 (nl)
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form

Legal Events

Date Code Title Description
PUE Assignment

Owner name: BROCADES-PHARMA B.V.

PL Patent ceased